Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38-Reference-Cited by-同舟云学术

Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38

Published:2017-10 Issue:4 Volume:82 Page:615-621
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Manes Marta¹,Alberici Antonella¹,Di Gregorio Eleonora²³,Boccone Loredana⁴,Premi Enrico¹,Mitro Nico⁵^ORCID,Pasolini Maria Pia⁶,Pani Claudia⁴,Paghera Barbara⁷,Perani Daniela⁸⁹¹⁰,Orsi Laura¹¹,Costanzi Chiara¹²,Ferrero Marta³,Zoppo Adele¹³,Tempia Filippo¹⁴,Caruso Donatella⁵,Grassi Mario¹⁵,Padovani Alessandro¹,Brusco Alfredo²³,Borroni Barbara¹

Affiliation:

1. Neurology Unit, Department of Clinical and Experimental Sciences; University of Brescia; Brescia

2. Medical Genetics Unit, City of Health and Science; University Hospital; Turin

3. Department of Medical Sciences; University of Turin; Turin

4. Microcitemie Regional Hospital, Brotzu Hospital; Cagliari

5. Department of Pharmacological and Biomolecular Sciences; University of Milan; Milan

6. Neurophysiology Unit, Spedali Civili; Brescia

7. Department of Nuclear Medicine; University of Brescia; Brescia

8. Vita-Salute San Raffaele University; Milan

9. Nuclear Medicine Unit, San Raffaele Hospital; Milan

10. Division of Neuroscience, San Raffaele Scientific Institute; Milan

11. Neurologic Division 1, Department of Neuroscience and Mental Health, University Hospital City of Health and Science of Turin; Turin

12. Neurology Unit, Cremona Hospital; Cremona

13. Endocrinological Unit, San Carlo Hospital; Paderno Dugnano Milan Italy

14. Neuroscience Institute Cavalieri Ottolenghi (NICO) and Department of Neuroscience; University of Turin; Turin

15. Department of Brain and Behavioral Sciences, Medical and Genomic Statistics Unit; University of Pavia; Pavia Italy

Funder

Fondazione Telethon

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference25 articles.

1. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies;Ruano;Neuroepidemiology,2014

2. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond;Durr;Lancet Neurol,2010

3. Movement disorders in spinocerebellar ataxias;Gaalen;Mov Disord,2011

4. Spinocerebellar ataxia: relationship between phenotype and genotype-a review;Sun;Clin Genet,2016

5. ELOVL5 mutations cause spinocerebellar ataxia 38;Gregorio;Am J Hum Genet,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Clinical Benefit of Very Long Chain Fatty Acid Supplementation in Spinocerebellar Ataxia Type 34;The Cerebellum;2024-05-21

2. Genetic Testing of Movements Disorders: A Review of Clinical Utility;Tremor and Other Hyperkinetic Movements;2024

3. Comparison of Two Therapeutic Approaches of Cerebellar Transcranial Direct Current Stimulation in a Sardinian Family Affected by Spinocerebellar Ataxia 38: a Clinical and Computerized 3D Gait Analysis Study;The Cerebellum;2023-08-04

4. Autosomal dominant cerebellar ataxias: new genes and progress towards treatments;The Lancet Neurology;2023-08

5. Spinocerebellar ataxia 38: structure–function analysis shows ELOVL5 G230V is proteotoxic, conformationally altered and a mutational hotspot;Human Genetics;2023-05-18